APO 150 (Nizatidine 150 mg)

Pill imprint APO 150 has been identified as Nizatidine 150 mg.

Nizatidine is used in the treatment of gerd; duodenal ulcer; indigestion; erosive esophagitis; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 150 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for APO 150 (Nizatidine 150 mg)

Nizatidine 150 mg APO 150
Nizatidine 150 mg APO 150
Nizatidine
Imprint:
APO
150
Strength:
150 mg
Color:
White & Yellow
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0230
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose monohydrate
stearic acid
magnesium silicate
gelatin
titanium dioxide
ferric oxide yellow
ammonia
alcohol
isopropyl alcohol
butyl alcohol
potassium hydroxide
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
55045-3748 Dispensing Solutions Inc. (repackager)
55887-0153 Diversified Healthcare Services Inc (repackager)
23490-6010 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web2)